GLIPR1 and neoplasm: We next examined the effect of silencing of RTVP-1 on the migration of GSCs, which are implicated in therapeutic resistance, tumor invasion and recurrence [38, 39] and found that silencing of RTVP-1 in these cells resulted in decreased migration and invasion.